Personalis 13D Filing Shows Tempus AI Reported A 15.1% Stake In The Co As Of July 3, 2024
Quantisnow Tempus AI shares are trading higher after the company announced it received U.S. FDA 510(k) clearance for Tempus ECG-AF device that uses AI to …
Read the original at quantisnow.com ↗
- Topics
- HealthcareBanking & Finance
- Mentions
- FDAUnited States
- Tags
- AI Use Case
- Tracked via
- Google Alert “that uses AI to”